A total of 123 patients with moderately advanced, cavitary lung disease caused by Mycobacterium avium complex untreated previously received different regimens of antituberculosis agents. The rate of sputum conversion (continuously negative cultures for six months or more) was compared among the regimens. It was shown that the regimens of rifampin + isoniazid + streptomycin and rifampin + isoniazid + enviomycin were superior to the regimens of streptomycin + isoniazid+ p-aminosalicylate, isoniazid alone or isoniazid + p-aminosalicylate. This finding demonstrated that the regimens including rifampin, isoniazid and streptomycin or enviomycin were really effective in the initial treatment of lung disease caused by M avium complex. reported that regimens containing three or more drugs were statistically more effective than regimens containing two drugs, but they did not demonstrate any significant difference in effectiveness for a particular combination of drugs. The purpose of the present study is to assess which combination of drugs is really effective in the initial treatment of pulmonary disease caused by the M avium complex.
A total of 123 patients with moderately advanced, cavitary lung disease caused by Mycobacterium avium complex untreated previously received different regimens of antituberculosis agents. The rate of sputum conversion (continuously negative cultures for six months or more) was compared among the regimens. It was shown that the regimens of rifampin + isoniazid + streptomycin and rifampin + isoniazid + enviomycin were superior to the regimens of streptomycin + isoniazid+ p-aminosalicylate, isoniazid alone or isoniazid + p-aminosalicylate. This finding demonstrated that the regimens including rifampin, isoniazid and streptomycin or enviomycin were really effective in the initial treatment of lung disease caused by M avium complex. r I therapeutic effect of antituberculosis agents in the treatment of pulmonary disease caused by Mycobacterium avium complex was reported by a number of investigators.' 10 However, almost all clinical investigations did not demonstrate any statistically significant difference among the regimens. Etzkorn et al 10 reported that regimens containing three or more drugs were statistically more effective than regimens containing two drugs, but they did not demonstrate any significant difference in effectiveness for a particular combination of drugs. The purpose of the present study is to assess which combination of drugs is really effective in the initial treatment of pulmonary disease caused by the M avium complex.
MATERIALS AND METHODS

Patients
The patients entering this hospital during a period of 21 years (1965 to 1985) were the subjects of the study. The patients were limited to those previously untreated by any antituberculosis agents and hospitalized for more than seven months. Success or failure in obtaining sputum conversion by initial treatment was compared among various regimens. The period of observation was from seven months to 18 years. Patients were restricted to those having moderately advanced, cavitary disease. In this hospital, approximately 220 patients with lung disease caused by the M avium complex were treated in this period. Of these, 123 patients were used in this study The background factors of the patients are shown in Table 1 .
Diagnosis
The diagnosis was made by the senior author throughout the study. Before 1970, the criteria of Yamamoto et al" were used. These required four or more isolations of mycobacteria that were considered as causative and showed more than 100 colonies on the isolation medium. After 1971, Tsukamura's criteria 1213 were used: in the presence of a new cavitary lesion on the roentgenogram, two *From the Department of Respiratory Diseases, the National Chubu Hospital, Obu, Aichi, Japan. Manuscript received June 9; revision accepted September 18. Reprint requests: Dr. Tsukamura, National Chubu Hospital, Obu, Aichi 474, Japan or more isolations of mycobacteria belonging to the same species by monthly sputum examination made in the initial three months; in the presence of a sclerotic cavitary lesion, three or more isolations of mycobacteria belonging to the same species, at least one of which showed more than 100 colonies.
For cultivation of acid-fast bacteria, Ogawa egg medium or Tween egg medium 14 (after 1977) were used. One morning sputum specimen was added by equal volume of a 2 or 4 percent hydroxide solution, according to the consistency of the sputum, and was shaken mechanically for 15 minutes at room temperature. Two loopsful of the specimen were inoculated onto one medium slant by spiral loop, which can deliver a 0.02-ml sample by one inoculation. The media were incubated at 37°C for eight weeks. The growth was read after incubation for four and eight weeks. The mycobacteria isolated were identified according to the methods described previously. 15 
Treatment
Medical treatment was carried out according to the physicians preference. Single to five-drug regimens were used for 6 to 12 months. Regimens not containing rifampin (RFP) were used before appearance of this drug. The administration was made as follows: streptomycin sulfate (SM), 1 g/day, twice weekly (when combined with isoniazid [INH] and p-aminosalicylate [PAS]) or 0.75 g/day for the initial three months and then 1 g/day twice weekly (when combined with RFP and INH); kanamycin sulfate (KM), 1 g/day, three times weekly; enviomycin sulfate (EVM) (a derivative of viomycin, which is fourfold stronger than viomycin in the in vitro activity and is less toxic; Toyo Jozo Co, Shizuoka, Japan), 1 g/day; three times weekly; INH, 0.2 to 0.4 g/day; PAS, 8 g/day; RFP 0.45 g/day; ethambutol (EB), 0.75 g or 1 g/da>:
Definition of Sputum Conversion
On admission, the patients were examined daily by smear and culture of sputum for three to seven days and thereafter monthly. The sputum conversion was defined as continuously negative cultures for six months or more. The efficacy of regimens was evaluated only by the rate of sputum conversion in the initial stage of drug administration, regardless of whether or not relapse later occurred. In most cases, successful regimens were continued for one year or more. (In Japan, medical treatment of tuberculosis patients is made without payment by patients, and the payment by the Ministry of Health and Welfare is guaranteed every six months.) 
